Demirkaya, M. Et Al. 2013. Randomized Comparison of Piperacillin-Tazobactam Plus Amikacin Versus Cefoperazone-Sulbactam Plus Amikacin for Management of Febrile Neutropenia in Children with Lymphoma and Solid Tumors. PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.30 , 141-148.

Demirkaya, M., Çelebi, S., Sevinir, B. B., & Hacimustafaoglu, M. K., (2013). Randomized Comparison of Piperacillin-Tazobactam Plus Amikacin Versus Cefoperazone-Sulbactam Plus Amikacin for Management of Febrile Neutropenia in Children with Lymphoma and Solid Tumors. PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.30, 141-148.

Demirkaya, Metin Et Al. "Randomized Comparison of Piperacillin-Tazobactam Plus Amikacin Versus Cefoperazone-Sulbactam Plus Amikacin for Management of Febrile Neutropenia in Children with Lymphoma and Solid Tumors," PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.30, 141-148, 2013

Demirkaya, Metin Et Al. "Randomized Comparison of Piperacillin-Tazobactam Plus Amikacin Versus Cefoperazone-Sulbactam Plus Amikacin for Management of Febrile Neutropenia in Children with Lymphoma and Solid Tumors." PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.30, pp.141-148, 2013

Demirkaya, M. Et Al. (2013) . "Randomized Comparison of Piperacillin-Tazobactam Plus Amikacin Versus Cefoperazone-Sulbactam Plus Amikacin for Management of Febrile Neutropenia in Children with Lymphoma and Solid Tumors." PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.30, pp.141-148.

@article{article, author={Metin Demirkaya Et Al. }, title={Randomized Comparison of Piperacillin-Tazobactam Plus Amikacin Versus Cefoperazone-Sulbactam Plus Amikacin for Management of Febrile Neutropenia in Children with Lymphoma and Solid Tumors}, journal={PEDIATRIC HEMATOLOGY AND ONCOLOGY}, year=2013, pages={141-148} }